ABL Bio Inc. (KOSDAQ: 298380)
South Korea
· Delayed Price · Currency is KRW
40,500
+5,400 (15.38%)
Oct 11, 2024, 9:00 AM KST
ABL Bio Revenue
ABL Bio had revenue of 8.44B KRW in the quarter ending June 30, 2024, a decrease of -1.73%. This brings the company's revenue in the last twelve months to 32.95B, down -66.11% year-over-year. In the year 2023, ABL Bio had annual revenue of 65.55B, down -2.61%.
Revenue (ttm)
32.95B
Revenue Growth
-66.11%
P/S Ratio
58.87
Revenue / Employee
323.08M
Employees
102
Market Cap
1,945.94B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65.55B | -1.75B | -2.61% |
Dec 31, 2022 | 67.30B | 61.97B | 1,162.19% |
Dec 31, 2021 | 5.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition